Participants n | 13 | 10 | 13 |
Males/females (% females) | 8/5 (38.5%) | 6/4 (40%) | 8/5 (38.5%) |
Age years | 60±9 | 60±9 | 65±5 |
BMI kg·m−2 | 25±3 | 27±4 | 26±3 |
FVC % predicted | 101±14 | 81±17 | 59±20* |
DLCO % predicted | | 69 ±14 | 48 ±15* |
6MWD m | | 558±107 | 397±71* |
6MWD % predicted | | 83±15 | 62±13* |
Hb g·L−1 | | 148±11 | 136±19 |
Hct L·L−1 | | 0.43±0.02 | 0.41±0.05 |
Estimated FIO2 | | | 0.45±0.1# |
Diagnosis | | | |
IPF | | 3 | 4 |
NSIP | | 1 | 3 |
IPF/COPD | | | 2 |
DIP | | 1 | |
COP | | 1 | |
NYD | | 1 | 1 |
Hypersensitivity pneumonia | | | 2 |
LAM | | | 1 |
Sjogren's | | 2 | |
RA-ILD | | 1 | |